Rajesh Kumar
Stock Analyst at HSBC
(3.30)
# 755
Out of 4,829 analysts
21
Total ratings
60%
Success rate
13.18%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Downgrades: Reduce | $1,150 → $700 | $755.57 | -7.35% | 2 | Apr 28, 2025 | |
| IQV IQVIA Holdings | Downgrades: Hold | $260 → $160 | $156.13 | +2.48% | 1 | Apr 25, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $33.51 | +25.34% | 1 | Apr 25, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $185 | $190.07 | -2.67% | 3 | Jun 5, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $432.59 | +54.88% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $200.83 | +39.42% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $378.75 | +21.45% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $17.96 | -27.62% | 1 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $48.18 | +10.00% | 2 | Oct 27, 2023 | |
| MRNA Moderna | Initiates: Reduce | $97 | $25.70 | +277.43% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $124 | $97.27 | +27.48% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $23.09 | +116.54% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $80.43 | +52.93% | 1 | Jul 14, 2023 |
Eli Lilly and Company
Apr 28, 2025
Downgrades: Reduce
Price Target: $1,150 → $700
Current: $755.57
Upside: -7.35%
IQVIA Holdings
Apr 25, 2025
Downgrades: Hold
Price Target: $260 → $160
Current: $156.13
Upside: +2.48%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $33.51
Upside: +25.34%
AbbVie
Jun 5, 2024
Upgrades: Buy
Price Target: $185
Current: $190.07
Upside: -2.67%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $432.59
Upside: +54.88%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $200.83
Upside: +39.42%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $378.75
Upside: +21.45%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $17.96
Upside: -27.62%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $48.18
Upside: +10.00%
Moderna
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $25.70
Upside: +277.43%
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $97.27
Upside: +27.48%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $23.09
Upside: +116.54%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $80.43
Upside: +52.93%